
Dying teen transferred, family told to arrange return of his body
They were further distressed by being told they needed to organise his body's repatriation to his hometown.
A complaint about the 19-year-old's care was referred to Health and Disability Commissioner by the coroner.
The young man – who died in 2015 – had undergone an operation in January that year related to his type 2 neurofibromatosis – a genetic condition that causes benign tumours to develop on nerves, particularly those in the skull and spine.
There were complications due to a post-operative infection and meningitis, which was treated successfully at a secondary hospital.
ADVERTISEMENT
The man – who was referred to in the commissioner's report as Mr B – continued to suffer from fluid building up around the brain and required regular release of cerebrospinal fluid through lumbar puncture.
He was admitted to hospital with ongoing headaches and vomiting in April.
A decision was made to hold off on further lumbar punctures due to concerns it could cause a hernia and to transfer him to another hospital via an air retrieval team.
The transfer was delayed due due to staffing issues and a lack of an available air ambulance.
Deputy commissioner Dr Vanessa Caldwell said Mr B was neurologically stable at the time and his transfer was scheduled for the next day.
However, while waiting he collapsed and his heart stopped.
He was then urgently transferred to another hospital, but his condition deteriorated and at the second hospital he was declared brain dead.
ADVERTISEMENT
Mr B's family told the commissioner they did not understand why he was not transferred by road when the air retrieval team was not available, and they did not understand why he was transferred to another hospital when his prognosis was poor.
The transfer meant they did not have a chance to say goodbye to him before his death.
The family also said they were asked if they would donate his organs only minutes after being told he was brain dead, which left them little time to consider their options.
They were also told by a social worker it was up to them to organise transport of his body back to where they lived, even though he qualified for travel assistance.
Health NZ apologised for the distress caused by the discussion related to organ donation and the miscommunication regarding transporting Mr B's body.
Dr Caldwell said the care provided to the man was at an appropriate standard and decisions, such as the air transfer, were made appropriately based on the information available to the team at the time.
Incorrect and minimal information was provided to the family once the man died and this had been particularly distressing for them, she said.
ADVERTISEMENT
She also had concerns about the communication between the air retrieval team and the teams treating Mr B.
Health New Zealand breached the patient's right to information under the Code of Health and Disability Services Consumers' Rights, the commissioner said.
A number of changes had been made since the young man's death, including the establishment of Health NZ, Dr Caldwell said.
The morning's headlines in 90 seconds, including wintry blast on the way, Gloriavale leader in court, and Liam Lawson picks up points. (Source: Breakfast)
"I am also mindful that providing recommendations at this stage for errors that happened some time ago is likely to have limited practical benefit."
She recommended Health NZ Southern and Health NZ Waitaha Canterbury provided a formal written apology for the breaches identified in the report within three weeks.
rnz.co.nz
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scoop
4 hours ago
- Scoop
Pharmac Expands Access To Meningococcal B Vaccine For Children Under 5
Pharmac is extending access to the meningococcal B vaccine (Bexsero), with up to 77,000 more children able to benefit. From 1 September 2025, all children under five years of age will be eligible for funded doses of Bexsero, regardless of whether they started or completed their vaccine course in their first year. This replaces the current catch-up programme, which ends on 31 August 2025. The vaccine is already part of the childhood immunisation schedule for children up to 12 months of age. The new eligibility criteria mean that children who missed earlier doses can still be protected. 'We know how serious meningococcal disease can be, especially for young children,' says Pharmac's Manager Pharmaceuticals Adrienne Martin. 'By expanding access, we're helping families complete their child's vaccine course and improving protection for those most at risk.' Children under five are the most vulnerable to serious illness from meningococcal disease. This change supports better protection for this high-risk group and makes it easier for families to access the vaccine. 'This decision is about removing barriers,' says Martin. 'We want to ensure that no child misses out on protection just because they couldn't complete their vaccine course in their first year.' Health New Zealand's National Public Health Director Dr Nick Chamberlain says it welcomes Pharmac's decision to extend access to the meningococcal B vaccine. 'Pharmac's move to extend access to Bexsero for all children under five is a significant step forward in protecting those most vulnerable to meningococcal disease. 'This change brings clarity for the health sector and removes barriers for families, making it easier to complete the vaccine course. Health New Zealand will continue working closely with providers to support the rollout and ensure eligible children receive this important protection,' said Dr Chamberlain. While the eligibility criteria for older children and adults at higher risk remain unchanged, Pharmac has clarified the wording to make it easier to understand. Teenagers and young adults living in shared accommodation, such as boarding schools, halls of residence, military barracks, and prisons, continue to be eligible under the current rules.


Otago Daily Times
6 hours ago
- Otago Daily Times
Meningococcal vaccine funding for all children under five
People who missed earlier doses could still be protected, potentially benefiting up to 77,000 more children. Thousands more children will be offered free protection against potentially deadly meningococcal B as Pharmac has decided to expand eligibility for the vaccine. From September 1, the government's drug-buying agency will fund the Bexsero vaccine for all children aged under five, regardless of whether they started or completed their course before turning one. This replaced the current catch-up programme which ends on August 31. Pharmac pharmaceuticals manager Adrienne Martin said under-fives were "the most vulnerable to serious illness from meningococcal disease". "This decision is about removing barriers. "We want to ensure that no child misses out on protection just because they couldn't complete their vaccine course in their first year." The vaccine was already part of the immunisation schedule for babies in their first year of life. The new criteria means those who missed earlier doses could still be protected, potentially benefiting up to 77,000 more children. Dr Nick Chamberlain, Health New Zealand's national public health director, said the decision was a significant step forward in protecting children. "This change brings clarity for the health sector and removes barriers for families, making it easier to complete the vaccine course. "Health New Zealand will continue working closely with providers to support the rollout and ensure eligible children receive this important protection." Teenagers and young adults living in shared accommodation (such as boarding schools, halls of residence, military barracks and prisons) continue to be eligible under current rules.

RNZ News
7 hours ago
- RNZ News
Nurses' strike: 4300 patient appointments, procedures postponed
More than 36,000 nurses, midwives and healthcare assistants walked off the job on Wednesday. Photo: Wallace Chapman Health NZ has work underway to rebook about 4300 patient appointments and procedures, which had to be postponed due to the 24-hour nurses' strike. More than 36,000 nurses, midwives and healthcare assistants - frustrated by what they say is Health NZ's refusal to commit to safe staffing levels in their collective agreement - walked off the job until 9am Thursday . Health NZ chief executive Dr Dale Bramley said the impact varied by hospital, depending on acute demand and the number of Nurses Organisation members who actually took strike action. "Despite heavy winter occupancy in some areas, our hospitals got through the strike without any serious incidents, which is a testament to all those staff and volunteers who provided support," he said. "While the strike lasted 24 hours, an enormous amount of planning work went on beforehand and there is a lot more work to do now the strike has finished." An estimated 4300 planned procedures and specialist appointments had to be deferred because of the strike, he said. "We remain very concerned about the significant number of patients who have had much-needed treatment deferred due to the strike. New appointments for those patients will be scheduled as soon as possible." Meanwhile, Health NZ was committed to getting a deal with the Nurses Organisation , and remained "completely committed to patient and staff safety", Bramley said. "We have more nurses working for Health NZ than ever before. "In the two years to March 2025, our nursing FTE increased by over 3000, turnover has dropped from 13.3 percent to 8.2 percent and our vacancy rate is now at a six-year low of 3.6 percent." The New Zealand Nurse Organisation has been approached for comment. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.